In: Journal of Clinical Microbiology, 2020, p. -
A series of clinical NDM-5-producing E. coli isolates obtained from two surveillance networks of carbapenem-producing Enterobacterales from 2018-2019, namely Switzerland (NARA) and Germany (SurvCARE), were analyzed. The 33 NDM-5- producing E. coli isolates were highly resistant to β-lactams including the novel ß- lactam/ß-lactamase inhibitor combinations (ceftazidime/avibactam, ...
|
In: Journal of Antimicrobial Chemotherapy, 2012, vol. 67, no. 8, p. 1861-1864
|
In: FEMS Microbiology Letters, 2006, vol. 265, no. 2, p. 244-248
|
In: International Journal of Antimicrobial Agents, 2018, vol. 52, no. 5, p. 740–741
|
In: FEMS Microbiology Letters, 2014, vol. 355, no. 1, p. 78-82
|
In: Journal of Antimicrobial Chemotherapy, 2014, vol. 69, no. 7, p. 2007-2008
We read with great interest two recent publications dealing with the same topic, i.e. the public health risk related to the occurrence of acquired carbapenemase-producing Gram-negative species in the animal world and the environment.1,2 Woodford et al.1 highlight the series of reports of carbapenemases found either in bacteria isolated from non-human sources or in Salmonella enterica subsp....
|
In: Journal of Antimicrobial Chemotherapy, 2014, vol. 69, no. 7, p. 2007-2008
|
In: Diagnostic Microbiology and Infectious Disease, 2018, vol. 90, no. 1, p. 7–10
The Rapid Polymyxin NP test has been recently developed to rapidly detect polymyxin resistance in Enterobacteriaceae. Here we evaluated this test for detecting MCR- 1/MCR-2-producing Enterobacteriaceae using a collection of 70 non-redundant strains either recovered from the environment, animals, or humans. Sensitivity and specificity were found to be 100%.
|
In: FEMS Microbiology Letters, 2015, vol. 362, no. 6, p. -
|
In: FEMS Microbiology Letters, 2014, vol. 356, no. 1, p. 134-140
|
